alexa
Reach Us +44-1764-910199
Anthropometric Measures And Type 2 Diabetes | 6518
ISSN: 2165-7904

Journal of Obesity & Weight Loss Therapy
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Anthropometric measures and type 2 diabetes

International Conference and Exhibition on Obesity & Weight Management

Qing Qiao

Accepted Abstracts: J Obes Wt Loss Ther

DOI: 10.4172/2165-7904.S1.006

Abstract
Both type 2 diabetes and obesity are increasing worldwide. Obesity has been well documented as a major modifiable risk factor for diabetes. Different surrogate anthropometric measures, such as body mass index, waist circumference, waist to hip ratio and waist to height ratio, have been proposed to define obesity in a clinical setting. These obesity indices have been used alone or frequently integrated into an algorithm to assess an individual?s risk to develop diabetes. The question is thus raised as to which of these obesity indicators is best at predicting type 2 diabetes. Another question often asked is where to set cut-off values for a positive diagnosis since a dichotomous variable is practically useful. Ethnic differences in obesity-diabetes relationship have hindered attempts to propose a universally accepted definition for obesity, but what exactly the ethnic differences are. All these will be addressed in the presentation.
Biography
Qing Qiao, a paediatrician, started to engage herself into research on epidemiology of type 2 diabetes since 1993, and completed her Ph.D in 1996 from Finland. Currently she is a senior research scientist in the AstraZeneca in Sweden, and an adjunct professor in the University of Helsinki, Finland. She has published more than 130 research articles and book chapters on type 2 diabetes, obesity, metabolic syndrome, cardiovascular diseases and cancers, and as an editor she recently published a book entitled ?Epidemiology of Type 2 Diabetes?.
Relevant Topics
Top